首席药师制度在静脉药物配置中心合理用药管理中的作用

发布时间：2018-05-17 04:10

本文选题：首席药师制度 + 静脉药物配置中心　；参考：《中国药物经济学》2016年11期

【摘要】：目的探讨首席药师制度在静脉药物配置中心(PIVAS)合理用药管理中的作用。方法选取2013年1月至2014年1月未实施首席药师制度的PIVAS审核的156 280份医嘱作为对照组;选取2014年3月至2015年3月实施首席药师制度的PIVAS审核的158 923份医嘱作为观察组。比较观察组与对照组干预前后不合理医嘱发生情况,分析观察组医嘱不合理用药情况及干预后医嘱修改情况。结果干预后,观察组不合理医嘱发生率明显少于对照组,差异有统计学意义(P0.05);观察组医嘱主要不合理用药类型为溶媒不合理,其次为浓度不合理;观察组687例不合理医嘱中,经联系护理人员修改3份,经联系医师修改619份。结论首席药师制度应用于PIVAS合理用药管理中,可以明显降低用药不合理医嘱发生率,有助于提高其合理用药管理水平,促进临床合理用药,确保患者用药安全。
[Abstract]:Objective to explore the role of chief pharmacist system in rational drug administration in intravenous Drug allocation Center (IVAS). Methods 156,280 medical orders from January 2013 to January 2014 were selected as control group, and 158,923 medical orders from PIVAS from March 2014 to March 2015 were selected as observation group. The occurrence of unreasonable doctor's orders before and after intervention was compared between the observation group and the control group. The irrational use of medical orders and the modification of doctors' orders after intervention were analyzed in the observation group. Results after intervention, the incidence of unreasonable medical orders in the observation group was significantly lower than that in the control group, and the difference was statistically significant (P 0.05). Three of them were revised by contact nurses and 619 by doctors. Conclusion the application of the chief pharmacist system in the rational drug use management of PIVAS can obviously reduce the incidence of irrational drug use, help to improve the management level of rational use of drugs, promote the rational use of drugs in clinic and ensure the safety of drug use in patients.
【作者单位】：江苏省苏州市江苏盛泽医院;
【分类号】：R95

【相似文献】